Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Novo-Nordisk ADR repsg 1 B Ord Shs NVO

Healthcare Biotechnology
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:NVO)

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

GlobeNewswire September 24, 2024

Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development

TheNewsWire June 11, 2024

Novo Nordisk launches national Wegovy® campaign, Power of Wegovy®

PR Newswire June 3, 2024

Wegovy® receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity

PR Newswire March 8, 2024

Novo Nordisk stock hits new high on next-gen weight-loss drug results

Jonathon Brown March 7, 2024

Novo Nordisk stock rallies on Wegovy diabetes drug trial results

Jonathon Brown August 8, 2023

Novo Nordisk takes actions to help protect US patients from unlawful sales of non-FDA approved medicines claiming to contain semaglutide

PR Newswire June 20, 2023

Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024

PR Newswire March 14, 2023

EXL Announces Appointment of Andreas Fibig to Board of Directors

GlobeNewswire January 12, 2023
View More News ››

Opinion & Analysis (NYSE:NVO)

Top First Quarter European ETFs

Benzinga.com  March 31, 2015

A Look At 4 ETFs From The 4 'Least Corrupt' Countries

Benzinga.com  December 4, 2014
View More Opinion ››

Bullboard Posts (NYSE:NVO)

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

JUST IN: $NVO 3 Fantastic Stocks That Could Enjoy a Santa Claus Rally2024-12-21 06:48:00 ET Santa Claus will soon be on his way...
whytestocks - 3 days ago

Got $250? 2 Healthcare Stocks to Buy and Hold Forever

BREAKING NEWS: $NVO Got $250? 2 Healthcare Stocks to Buy and Hold Forever2024-12-19 06:15:00 ET One of the great things about the stock...
whytestocks - 4 days ago

Novo Nordisk: Big Pharma’s Next Crown Jewel?

Potential Medicare and Medicaid coverage expansion for anti-obesity drugs could be a game-changer. I'm bullish on NVO's long-term...
Trader19Swift - December 2, 2024

Novo Nordisk's $600 Million Gambit Could Be a Game Changer f

JUST IN: $NVO Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why.2024-09-26 05:40:00 ET Novo...
whytestocks - September 26, 2024

Eli Lilly Just Made Zepbound Even More Appealing. Here's Wha

Just In: $NVO Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.2024-09-05 08:15:00 ET One...
whytestocks - September 5, 2024

Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrive

NEWS: $NVO Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived2024-08-18 14:10:00 ET Over the last couple of years, the...
whytestocks - August 18, 2024
View more Bullboard ››

Freegold Ventures Limited

Freegold Ventures Limited

Freegold Ventures Limited is a Canada-based company focused on exploration in Alaska. The Company holds Golden Summit Gold ...
View More »